Gentle Patches NAD+ Review: Right Ingredients, Undisclosed Dose

Why NMN rather than NAD+ is the correct choice

Start with the compliment, because it is real and it distinguishes this product from most of what we review. NAD+ itself is a poor thing to put in a supplement: it is a dinucleotide of about 663 daltons carrying two phosphate groups, it is unstable, and it is broken down before it reaches cells intact. Companies that print NAD+ on the bag and put NAD+ in the bag have made a mistake. Gentle Patches has not. It uses nicotinamide mononucleotide, the direct precursor, which is what a competent formulator would specify.

The TMG inclusion is a further point in its favour, and a slightly technical one. Clearing nicotinamide consumes methyl groups, so people taking NAD+ precursors at meaningful doses are sometimes advised to co-supplement a methyl donor. Trimethylglycine is exactly that. Whoever specified this blend understood the pathway. Resveratrol is the weakest of the three — the sirtuin-activation story around it has not held up in humans as cleanly as it once promised — but it is a conventional, harmless inclusion in this category.

So the criticism that follows is not that this is a fake formula assembled by someone who does not know what NAD+ is. It is that a good ingredient list has been put into a delivery format that cannot plausibly deliver it, at a quantity the buyer is never told.

Size is not the objection here — dose is

We reviewed this company's GLP-1 patch separately and the objection there was absolute: semaglutide is about 4,114 daltons against a skin exclusion threshold of roughly 500, so no patch can carry it. That argument does not transfer, and it would be sloppy to pretend it does. NMN is about 334 daltons, resveratrol 228, TMG 117. All three are under the ceiling. Nothing about their size rules them out.

The real constraint is how much a patch can move, and NMN is a bad candidate for reasons other than mass. It is a phosphorylated nucleotide, zwitterionic and highly water-soluble, and the stratum corneum is a lipid barrier — polar, charged molecules cross it poorly regardless of being small. Compare the yardsticks: a nicotine patch, working with a small lipophilic molecule that permeates skin unusually well, delivers something like 7 to 21 mg over 24 hours. Fentanyl patches work in micrograms per hour.

Now the comparison that matters. Human oral NMN trials dose in the hundreds of milligrams daily — 250 mg is the common figure, and dose-ranging work has extended to 900 mg. For a patch to be doing what oral supplementation does, it would need to deliver a quantity of a poorly-permeating hydrophilic compound that exceeds what optimised transdermal systems achieve with far friendlier molecules. We are not aware of any published human study showing that transdermal NMN raises blood NAD+ at all.

And here the missing number stops being an oversight and becomes the centre of the review. If the bag said 250 mg, a reader could weigh that against trial doses and against the plausibility of the route. Because no figure is published anywhere — not on the landing page, not in the catalogue data, not in a supplement facts panel — the single most important variable is the one the buyer cannot see. The company claims its patches are “Triple-Tested for Purity, Delivery & Hypoallergenic Adhesive.” Delivery is one of the three things it says it tests. No delivery data is published, and the word third-party does not appear on the page.

The claims, and how they are sourced

The headline statistic is that 89% of users noticed increased energy after two to four weeks. To the company's credit, the page does say where this comes from: a detailed survey of 2,142 respondents. That is more transparent than the equivalent claim on their weight-loss page, and it is a subjective endpoint rather than a quantified physical outcome, so it is far less objectionable.

It is still not evidence. An unblinded, uncontrolled customer survey measuring self-reported energy is close to a worst case for placebo influence — people who bought a product for fatigue, applied it daily for a month, and were then asked whether they felt more energetic. No methodology, sampling frame or response rate is published. Self-reported vitality is precisely the outcome that improves in placebo arms of real trials.

Two other claims deserve flagging. The page states NAD+ levels drop by up to 50 percent by your 40s, attributed to “research shows” with no citation; age-related NAD+ decline is real in some tissues, but that particular figure is generalised well past what the underlying measurements support. And the opening copy asks whether you are struggling with fatigue, achy joints, inflammation or brain fog — naming inflammation and joint symptoms as the problem this product addresses, on a page that also carries a disclaimer stating it is not intended to treat any disease. Those two things sit uneasily together.

What is actually in Gentle Patches NAD+?

Three ingredients are named on the landing page: nicotinamide mononucleotide (NMN), resveratrol and trimethylglycine (TMG). Those are the right choices — NMN is a direct NAD+ precursor, and TMG is a methyl donor commonly paired with it for a real biochemical reason. What is missing is the quantity. We ran a regex for milligram figures across the landing page and all 83 of the company's product listings and found none. No supplement facts panel is published anywhere we could find.

Why does the dose matter so much for a patch?

Because it is the whole question. Published human NMN trials use daily doses in the hundreds of milligrams — 250 mg is common, and dose-ranging work has gone to 900 mg. Transdermal patches deliver far less than that in total: a nicotine patch delivers roughly 7 to 21 mg across 24 hours, and that is for a small, lipophilic molecule that crosses skin unusually well. NMN is a phosphorylated, zwitterionic, highly water-soluble nucleotide, which is close to the worst case for passive skin permeation. Without a stated dose there is no way to check whether the patch delivers a fraction of a trial dose or a rounding error.

Is the molecule too big to cross skin, like semaglutide?

No, and we want to be precise about that. NMN is about 334 daltons, resveratrol 228 and TMG 117 — all below the roughly 500-dalton ceiling that governs passive skin penetration. This is genuinely different from the company's GLP-1 patch, where semaglutide at about 4,114 daltons is excluded outright. Here the objection is not size, it is flux and dose: small enough to cross is not the same as crossing in useful amounts, and hydrophilic phosphorylated compounds cross poorly.

Is the 30-day money-back guarantee real?

It is much narrower than the landing page implies. The published Returns & Refunds Policy requires product to be unopened, unused and in its original sealed packaging, and states that anything opened or used is not eligible for return or refund. So the guarantee covers patches you never tried. The landing page also advertises free returns; the policy says all return shipping is the customer's responsibility, that the company does not generate return labels under any circumstances, that a $5 restocking fee applies to all returns, and that shipping fees are non-refundable.

Will I be put on a subscription?

By default, effectively yes. The large price on each bundle is the subscription price and the one-time price sits underneath in smaller text — $29.74 subscribed versus $51.91 once for a single bag. Each tier carries the line pause, skip or cancel anytime. The subscription terms themselves are reasonable: cancel at least 24 hours before the next billing date, via a link in your order confirmation email or by emailing support. Note this differs from the company's GLP-1 patch page, where every bundle is labelled a one-time purchase.

Who is the seller, and where are they based?

The legal entity disclosed in the site footer is UAB Prolong Lab, Dominikonų g. 11-101, 01131 Vilnius, Lithuania. UAB is the Lithuanian private limited company form. Disclosing the entity and street address is more than many operations in this category do, and we credit it. It also means a US buyer's practical recourse in a dispute runs through a Lithuanian company, which is worth knowing before you spend.

Does NAD+ really drop 50% by age 40?

That figure is thinly sourced for the weight it carries. NAD+ does decline with age in various tissues, and that is a real and active area of research. But the specific up-to-50-percent-by-40 number is generalised from small tissue-specific measurements — skin, for example — into a claim about your whole body, and the landing page attributes it to research shows with no citation attached. Treat it as marketing shorthand rather than an established parameter.

What should I do instead?

If you want to try an NAD+ precursor, buy an oral NMN or nicotinamide riboside product that prints the milligrams on the label, so you can compare what you are taking against the doses used in published trials. The honest state of the evidence is that oral NMN reliably raises blood NAD+ markers, while whether that produces the energy, recovery and longevity benefits people buy it for is still unsettled. A patch with no stated dose puts you a step further from knowing anything.